Lilly subsidiary to build R&D facility in New York

NEW YORK An Indianapolis-based drug maker will be the first tenant of a new research and development park in New York.

Eli Lilly & Co. announced during a lease-signing event this week that the new Alexandria Center for Science and Technology at East River Science Park would house subsidiary ImClone Systems’ research division, including at least 125 scientists. ImClone’s manufacturing, development and administrative divisions will remain in New Jersey.

Lilly’s decision to build ImClone’s research division there drew praise from New York Mayor Michael Bloomberg.

“We set out to create the East River Science Park to provide today’s bioscience companies with the state-of-the-art commercial lab space they need to locate and expand,” Bloomberg said in a statement. “Eli Lilly & Co.’s decision to become its anchor tenant is evidence that our work is paying off.”